Insulin Directly Reduces Platelet Sensitivity to Aggregating Agents: Studies In Vitro and In Vivo

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Diabetes

• Publication date

  1988-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2337/diab.37.6.780PMID 2838353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• One, two, three or more pathways for platelet aggregation.

  2009cited by this paper
• Ouabain increases the calcium concentration in intracellular stores involved in stimulus-response coupling in human platelets.

  1990cited by this paper
• Reduction of platelet aggregation induced by euglycaemic insulin clamp

  1987cited by this paper
• Studies on Mechanisms Involved in Hypoglycemia-Induced Platelet Activation

  1986cited by this paper
• Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from Type 1 (insulin-dependent) diabetic patients

  1986cited by this paper
• Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2.

  1984cited by this paper
• Red Cell Deformability, Platelet Aggregation, and Insulin Action

  1983cited by this paper
• Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein.

  1983cited by this paper
• Do Platelets Have Anything To Do With Diabetic Microvascular Disease?

  1983cited by this paper
• Calcium ions, drug action and platelet function.

  1982cited by this paper
• Effects of insulin on erythrocyte deformability in diabetics--relationship between erythrocyte deformability and platelet aggregation.

  1981cited by this paper
• Dose-response characteristics for effects of insulin on production and utilization of glucose in man.

  1981cited by this paper
• Insulin action.

  1981cited by this paper
• Diabetes and atherosclerosis — The role of insulin

  1979cited by this paper
• Reduced Erythrocyte Deformability in Diabetes

  1978cited by this paper
• Platelet function and diabetes mellitus.

  1978cited by this paper
• Regulation of blood platelet function by cyclic nucleotides.

  1978cited by this paper
• Fibrinogen and ADP-induced platelet aggregation.

  1978cited by this paper
• The effect of insulin and glucose on sterol synthesis in cultured rat arterial smooth muscle cells.

  1977cited by this paper
• Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.

  1977cited by this paper
• Effect of Insulin on the Proliferation of Cultured Primate Arterial Smooth Muscle Cells

  1975cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Arachidonic acid-induced human platelet aggregation and prostaglandin formation.

  1973cited by this paper
• Studies on the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine.

  1969cited by this paper
• Effects of adrenaline on human blood platelets

  1967cited by this paper
• Secondary Clumping Effect in Human Citrated Platelet-Rich Plasma Produced by Adenosine Diphosphate and Adrenaline

  1966cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Acetylsalicylic acid and vorapaxar are less active, while 4-methylcatechol is more active, in type 1 diabetic patients compared to healthy controls

  2025cites this paper
• Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease

  2023cites this paper
• To study the role of hematological biomarkers in type 2 diabetes patients with diabetic retinopathy

  2023cites this paper
• Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study

  2022cites this paper
• Hyperinsulinaemic hypoglycaemia in non-anaesthetized Göttingen minipigs induces a counter-regulatory endocrine response and electrocardiographic changes

  2021cites this paper
• Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease

  2020cites this paper
• Platelet Measurements and Type 2 Diabetes: Investigations in Two Population-Based Cohorts

  2020cites this paper
• Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies

  2019cites this paper
• Platelet morphology, bleeding time & clotting time in diabetic & healthy females

  2018cites this paper
• The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation

  2018cites this paper
• The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes – A Cross-over Study

  2018cites this paper
• Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.

  2017cites this paper
• New insights into the role of adipose tissue in thrombosis

  2017cites this paper
• The structural and functional changes of blood cells and molecular components in diabetes mellitus

  2017cites this paper
• Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults

  2017cites this paper
• Cardiovascular risk assessment in ecuadorian elderly population yield of four different models

  2017cites this paper
• Mechanisms of Platelet Activation in Diabetes Mellitus

  2017cites this paper
• Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans.

  2016cites this paper
• Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.

  2016cites this paper
• TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction

  2016cites this paper
• Potential Role of Protein Disulfide Isomerase in Metabolic Syndrome-Derived Platelet Hyperactivity

  2016cites this paper
• Small for Gestational Age and Magnesium: Intrauterine magnesium deficiency may induce metabolic syndrome in later life

  2015cites this paper
• Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes.

  2015cites this paper
• Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.

  2015cites this paper
• Nonesterified Fatty Acids, Albumin, and Platelet

  2015cites this paper
• Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation

  2015cites this paper
• Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus

  2015cites this paper
• Nonesterified Fatty Acids, Albumin, and Platelet Aggregation

  2015cites this paper
• Clopidogrel-related platelet inhibition: correlation with peri-operative adverse events in neurointerventional procedures

  2014cites this paper
• Hemostatic factors and the metabolic syndrome.

  2014cites this paper
• Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome

  2013cites this paper
• Local insulin application on the carotid artery inhibits neointima formation.

  2013cites this paper
• Platelet activity in Chinese obese adolescents with and without insulin resistance

  2013cites this paper
• Molecular interplay between platelets and the vascular wall in thrombosis and hemostasis.

  2013cites this paper
• Platelet activation in obesity and metabolic syndrome

  2012cites this paper
• The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance

  2012cites this paper
• Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease

  2012cites this paper
• Cardioprotective and antihypertensive effects of Enicostemma littorale Blume extract in fructose-fed rats.

  2012cites this paper
• Chronic Low-grade Inflammation and Haematological, Circulatory, Metabolic, and Hepatic Abnormalities in Childhood Obesity

  2011cites this paper
• A Novel Small Molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose Mimics the Antiplatelet Actions of Insulin

  2011cites this paper
• Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective

  2011cites this paper
• Effects of insulin on the vasculature.

  2011cites this paper
• Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study

  2011cites this paper
• Determinants of increased cardiovascular disease in obesity and metabolic syndrome.

  2011cites this paper
• Vasculoprotective Effects of Insulin and Resveratrol In Vivo

  2011cites this paper
• Low insulin level is associated with aortic stiffness

  2011cites this paper
• Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

  2010cites this paper
• Intracellular magnesium of obese and type 2 diabetes mellitus children

  2010cites this paper
• Platelets : with special reference to platelet density subpopulations, stable coronary heart disease and atrial fibrillation

  2010cites this paper
• U-shaped relationship between insulin level and coronary artery calcification (CAC).

  2010cites this paper
• Platelet aggregation responses in type 2 diabetic patients

  2010cites this paper
• Platelet Tissue Factor Synthesis in Type 2 Diabetic Patients Is Resistant to Inhibition by Insulin

  2010cites this paper
• Enhanced platelet aggregation, hyperinsulinemia and low testosterone level in monosodium glutamate obese rats.

  2010cites this paper
• In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin

  2010cites this paper
• Role of adipose tissue in haemostasis, coagulation and fibrinolysis

  2009cites this paper
• Platelet dysfunction in central obesity.

  2009cites this paper
• Insulin resistance as an independent risk factor for cardiovascular disease : clinical assessment and therapy approaches

  2009cites this paper
• Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy

  2008cites this paper
• Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.

  2008cites this paper
• The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects

  2007cites this paper
• Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population

  2007cites this paper
• Intracellular Magnesium and Adipokines in Umbilical Cord Plasma and Infant Birth Size

  2007cites this paper
• Individual variation in in vitro efficacy of antiplatelet medication - aspirin and clopidogrel

  2007cites this paper
• Association of Insulin Resistance and Hematologic Parameters: Study of a Middle‐aged and Elderly Chinese Population in Taiwan

  2006cites this paper
• Inhibitory Effects of Insulin and Aggregatory Response in Hypertensive Subjects on Intracellular Calcium of Platelets Are Impaired with Insulin Resistance

  2006cites this paper
• Platelet resistance to the anti-aggregating agents in the insulin resistant states.

  2006cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  2005cites this paper
• Diabetes mellitus und das Gerinnungssystem

  2005cites this paper
• Alterations in Thrombosis and Fibrinolysis in the Metabolic Syndrome

  2005cites this paper
• Insulin Induces the Release of Vasodilator Compounds From Platelets by a Nitric Oxide–G Kinase–VAMP-3–dependent Pathway

  2004cites this paper
• Vascular and Platelet Function in Insulin Resistance

  2004cites this paper
• Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.

  2004cites this paper
• Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity

  2004cites this paper
• Relationship of intracellular magnesium of cord blood platelets to birth weight.

  2004cites this paper
• Prevention of cardiovascular disease in type-2 diabetes: How to improve the clinical efficacy of aspirin

  2004cites this paper
• Endothelial dysfunction and hypertension in diabetes mellitus.

  2004cites this paper
• Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients.

  2003cites this paper
• Intracellular magnesium of platelets in children with diabetes and obesity.

  2003cites this paper
• Platelet abnormalities in diabetes mellitus

  2003cites this paper
• The Syndrome of Insulin Resistance and Its Links to Atherosclerosis

  2003cites this paper
• Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects

  2003cites this paper
• HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

  2002cites this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cites this paper
• Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation.

  2002cites this paper
• Effects of insulin on platelet and leukocyte activity in whole blood.

  2002cites this paper
• Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects.

  2002cites this paper
• Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function.

  2002cites this paper
• Insulin resistance syndrome : clustering of thrombotic risk factors Insulin Resistance Syndrome

  2002cites this paper
• Insulin resistance syndrome: interaction with coagulation and fibrinolysis.

  2002cites this paper
• Insulin action on large artery stiffness in normal and insulin resistant subjects

  2001cites this paper
• Platelet dysfunction in type 2 diabetes.

  2001cites this paper
• Treatment for the procoagulant state in type 2 diabetes.

  2001cites this paper
• Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice: Pleiotropic Effects on CD36 Expression and HDL

  2001cites this paper
• Tetsuya Effects on CD 36 Expression and HDL Knockout Mice : Pleiotropic − Troglitazone Inhibits Atherosclerosis in Apolipoprotein

  2001cites this paper
• Obesity Inhibition of Platelet-Collagen Interaction : An In Vivo Action of Insulin Abolished

  2001cites this paper
• Insulin enhances platelet activation in vitro.

  2001cites this paper
• Can magnesium act as a second messenger? Current data on translocation induced by various biologically active substances.

  2000cites this paper
• Diminished wave reflection in the aorta. A novel physiological action of insulin on large blood vessels.

  1999cites this paper
• Differential alterations of spontaneous and stimulated 45Ca(2+) uptake by platelets from patients with type I and type II diabetes mellitus.

  1999cites this paper
• Increasing neopterin and decreasing endothelin-1 in plasma during insulin infusion in women.

  1999cites this paper